Source: FinSMEs

Amalgam: Amalgam Rx Receives Investment From CVS Health Ventures

Amalgam Rx, a Wilmington, DE-based company which specializes in enabling data-driven health care decision making, received an investment of undisclosed amount from CVS Health Ventures in its Series B round. The company intends to use the funds to expand operations and its business reach. The investment supports the scaling of Amalgam's EHR-integrated clinical decision support [...]The post Amalgam Rx Receives Investment From CVS Health Ventures appeared first on FinSMEs.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Ryan Sysko's photo - Founder & CEO of Amalgam

Founder & CEO

Ryan Sysko

CEO Approval Rating

100/100

Read more